The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis
Autoantibody responses increase years before the onset of inflammatory arthritis (IA) and are stable during transitioning from clinically suspect arthralgia (CSA) to IA. Cytokine and chemokine levels also increase years before IA onset. However, the course in the at-risk stage of CSA during progress...
Gespeichert in:
| Veröffentlicht in: | Rheumatology (Oxford, England) England), 2024-02, Vol.63 (2), p.563-570 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 570 |
|---|---|
| container_issue | 2 |
| container_start_page | 563 |
| container_title | Rheumatology (Oxford, England) |
| container_volume | 63 |
| creator | Heutz, Judith W Rogier, Cleo Niemantsverdriet, Ellis van den Eeden, Susan J F de Jong, Pascal H P Lubberts, Erik Geluk, Annemieke van der Helm-van Mil, Annette H M |
| description | Autoantibody responses increase years before the onset of inflammatory arthritis (IA) and are stable during transitioning from clinically suspect arthralgia (CSA) to IA. Cytokine and chemokine levels also increase years before IA onset. However, the course in the at-risk stage of CSA during progression to disease or non-progression is unknown. To increase the understanding of processes mediating disease development, we studied the course of cytokine, chemokine and related receptors gene expression in CSA patients during progression to IA and in CSA patients who ultimately did not develop IA.
Whole-blood RNA expression of 37 inflammatory cytokines, chemokines and related receptors was determined by dual-colour reverse transcription multiplex ligation-dependent probe amplification in paired samples of CSA patients at CSA onset and either at IA development or after 24 months without IA development. ACPA-positive and ACPA-negative CSA patients developing IA were compared at CSA onset and during progression to IA. Generalised estimating equations tested changes over time. A false discovery rate approach was applied.
None of the cytokine/chemokine genes significantly changed in expression between CSA onset and IA development. In CSA patients without IA development, G-CSF expression decreased (P = 0.001), whereas CCR6 and TNIP1 expression increased (P |
| doi_str_mv | 10.1093/rheumatology/kead238 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2823497237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2823497237</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-28ccf2f9381675de39641f72c8bd9545a66287f4db62f23a01ba71b8249907473</originalsourceid><addsrcrecordid>eNpNkdtKxDAQhoMont9AJJferJtT2_RSxBMI3uh1SdNJN27a1CQF-wy-tF12V7yZmR_mmxnmR-iKkltKSr4MKxg7lbzz7bRcg2oYlwfolIqcLQjn7PCvZuIEncX4SQjJKJfH6IQXTM5CnqKf9xVg7ccQAXuD9ZT82vaAVd9gvYJuq1qYA3wPAWK0vse2x9rZ3mrl3ITjGAfQCauQVkG51io8qGShTxE3Y7B9i4fg2z2c_Mwbp7rN9WHaYjbZeIGOjHIRLnf5HH08PrzfPy9e355e7u9eF5pnPC2Y1NowU3JJ8yJrgJe5oKZgWtZNmYlM5TmThRFNnTPDuCK0VgWtJRNlSQpR8HN0s507X_U1QkxVZ6MG51QPfowVk4yLsmB80yq2rTr4GAOYagi2U2GqKKk2NlT_bah2NszY9W7DWHfQ_EH7v_Nf30eMhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2823497237</pqid></control><display><type>article</type><title>The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Heutz, Judith W ; Rogier, Cleo ; Niemantsverdriet, Ellis ; van den Eeden, Susan J F ; de Jong, Pascal H P ; Lubberts, Erik ; Geluk, Annemieke ; van der Helm-van Mil, Annette H M</creator><creatorcontrib>Heutz, Judith W ; Rogier, Cleo ; Niemantsverdriet, Ellis ; van den Eeden, Susan J F ; de Jong, Pascal H P ; Lubberts, Erik ; Geluk, Annemieke ; van der Helm-van Mil, Annette H M</creatorcontrib><description>Autoantibody responses increase years before the onset of inflammatory arthritis (IA) and are stable during transitioning from clinically suspect arthralgia (CSA) to IA. Cytokine and chemokine levels also increase years before IA onset. However, the course in the at-risk stage of CSA during progression to disease or non-progression is unknown. To increase the understanding of processes mediating disease development, we studied the course of cytokine, chemokine and related receptors gene expression in CSA patients during progression to IA and in CSA patients who ultimately did not develop IA.
Whole-blood RNA expression of 37 inflammatory cytokines, chemokines and related receptors was determined by dual-colour reverse transcription multiplex ligation-dependent probe amplification in paired samples of CSA patients at CSA onset and either at IA development or after 24 months without IA development. ACPA-positive and ACPA-negative CSA patients developing IA were compared at CSA onset and during progression to IA. Generalised estimating equations tested changes over time. A false discovery rate approach was applied.
None of the cytokine/chemokine genes significantly changed in expression between CSA onset and IA development. In CSA patients without IA development, G-CSF expression decreased (P = 0.001), whereas CCR6 and TNIP1 expression increased (P < 0.001 and P = 0.002, respectively) over a 2 year period. Expression levels in ACPA-positive and ACPA-negative CSA patients who developed IA were similar.
Whole-blood gene expression of assessed cytokines, chemokines and related receptors did not change significantly from CSA to IA development. This suggests that changes in expression of these molecules may not be related to the final process of developing chronicity and may have occurred preceding CSA onset. Changes in gene expression in CSA patients without IA development may provide clues for processes related to resolution.</description><identifier>ISSN: 1462-0324</identifier><identifier>ISSN: 1462-0332</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kead238</identifier><identifier>PMID: 37280058</identifier><language>eng</language><publisher>England</publisher><subject>Arthralgia - genetics ; Arthritis, Rheumatoid - genetics ; Chemokines - genetics ; Cytokines - genetics ; Gene Expression ; Humans</subject><ispartof>Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.563-570</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-28ccf2f9381675de39641f72c8bd9545a66287f4db62f23a01ba71b8249907473</citedby><cites>FETCH-LOGICAL-c353t-28ccf2f9381675de39641f72c8bd9545a66287f4db62f23a01ba71b8249907473</cites><orcidid>0000-0002-2126-7922 ; 0000-0002-3845-3019 ; 0000-0003-3783-7042 ; 0000-0002-5781-3817 ; 0000-0001-8555-2872 ; 0000-0001-8572-1437 ; 0000-0001-6628-6222 ; 0000-0002-3566-040X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37280058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heutz, Judith W</creatorcontrib><creatorcontrib>Rogier, Cleo</creatorcontrib><creatorcontrib>Niemantsverdriet, Ellis</creatorcontrib><creatorcontrib>van den Eeden, Susan J F</creatorcontrib><creatorcontrib>de Jong, Pascal H P</creatorcontrib><creatorcontrib>Lubberts, Erik</creatorcontrib><creatorcontrib>Geluk, Annemieke</creatorcontrib><creatorcontrib>van der Helm-van Mil, Annette H M</creatorcontrib><title>The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><description>Autoantibody responses increase years before the onset of inflammatory arthritis (IA) and are stable during transitioning from clinically suspect arthralgia (CSA) to IA. Cytokine and chemokine levels also increase years before IA onset. However, the course in the at-risk stage of CSA during progression to disease or non-progression is unknown. To increase the understanding of processes mediating disease development, we studied the course of cytokine, chemokine and related receptors gene expression in CSA patients during progression to IA and in CSA patients who ultimately did not develop IA.
Whole-blood RNA expression of 37 inflammatory cytokines, chemokines and related receptors was determined by dual-colour reverse transcription multiplex ligation-dependent probe amplification in paired samples of CSA patients at CSA onset and either at IA development or after 24 months without IA development. ACPA-positive and ACPA-negative CSA patients developing IA were compared at CSA onset and during progression to IA. Generalised estimating equations tested changes over time. A false discovery rate approach was applied.
None of the cytokine/chemokine genes significantly changed in expression between CSA onset and IA development. In CSA patients without IA development, G-CSF expression decreased (P = 0.001), whereas CCR6 and TNIP1 expression increased (P < 0.001 and P = 0.002, respectively) over a 2 year period. Expression levels in ACPA-positive and ACPA-negative CSA patients who developed IA were similar.
Whole-blood gene expression of assessed cytokines, chemokines and related receptors did not change significantly from CSA to IA development. This suggests that changes in expression of these molecules may not be related to the final process of developing chronicity and may have occurred preceding CSA onset. Changes in gene expression in CSA patients without IA development may provide clues for processes related to resolution.</description><subject>Arthralgia - genetics</subject><subject>Arthritis, Rheumatoid - genetics</subject><subject>Chemokines - genetics</subject><subject>Cytokines - genetics</subject><subject>Gene Expression</subject><subject>Humans</subject><issn>1462-0324</issn><issn>1462-0332</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkdtKxDAQhoMont9AJJferJtT2_RSxBMI3uh1SdNJN27a1CQF-wy-tF12V7yZmR_mmxnmR-iKkltKSr4MKxg7lbzz7bRcg2oYlwfolIqcLQjn7PCvZuIEncX4SQjJKJfH6IQXTM5CnqKf9xVg7ccQAXuD9ZT82vaAVd9gvYJuq1qYA3wPAWK0vse2x9rZ3mrl3ITjGAfQCauQVkG51io8qGShTxE3Y7B9i4fg2z2c_Mwbp7rN9WHaYjbZeIGOjHIRLnf5HH08PrzfPy9e355e7u9eF5pnPC2Y1NowU3JJ8yJrgJe5oKZgWtZNmYlM5TmThRFNnTPDuCK0VgWtJRNlSQpR8HN0s507X_U1QkxVZ6MG51QPfowVk4yLsmB80yq2rTr4GAOYagi2U2GqKKk2NlT_bah2NszY9W7DWHfQ_EH7v_Nf30eMhw</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Heutz, Judith W</creator><creator>Rogier, Cleo</creator><creator>Niemantsverdriet, Ellis</creator><creator>van den Eeden, Susan J F</creator><creator>de Jong, Pascal H P</creator><creator>Lubberts, Erik</creator><creator>Geluk, Annemieke</creator><creator>van der Helm-van Mil, Annette H M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2126-7922</orcidid><orcidid>https://orcid.org/0000-0002-3845-3019</orcidid><orcidid>https://orcid.org/0000-0003-3783-7042</orcidid><orcidid>https://orcid.org/0000-0002-5781-3817</orcidid><orcidid>https://orcid.org/0000-0001-8555-2872</orcidid><orcidid>https://orcid.org/0000-0001-8572-1437</orcidid><orcidid>https://orcid.org/0000-0001-6628-6222</orcidid><orcidid>https://orcid.org/0000-0002-3566-040X</orcidid></search><sort><creationdate>20240201</creationdate><title>The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis</title><author>Heutz, Judith W ; Rogier, Cleo ; Niemantsverdriet, Ellis ; van den Eeden, Susan J F ; de Jong, Pascal H P ; Lubberts, Erik ; Geluk, Annemieke ; van der Helm-van Mil, Annette H M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-28ccf2f9381675de39641f72c8bd9545a66287f4db62f23a01ba71b8249907473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Arthralgia - genetics</topic><topic>Arthritis, Rheumatoid - genetics</topic><topic>Chemokines - genetics</topic><topic>Cytokines - genetics</topic><topic>Gene Expression</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heutz, Judith W</creatorcontrib><creatorcontrib>Rogier, Cleo</creatorcontrib><creatorcontrib>Niemantsverdriet, Ellis</creatorcontrib><creatorcontrib>van den Eeden, Susan J F</creatorcontrib><creatorcontrib>de Jong, Pascal H P</creatorcontrib><creatorcontrib>Lubberts, Erik</creatorcontrib><creatorcontrib>Geluk, Annemieke</creatorcontrib><creatorcontrib>van der Helm-van Mil, Annette H M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heutz, Judith W</au><au>Rogier, Cleo</au><au>Niemantsverdriet, Ellis</au><au>van den Eeden, Susan J F</au><au>de Jong, Pascal H P</au><au>Lubberts, Erik</au><au>Geluk, Annemieke</au><au>van der Helm-van Mil, Annette H M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>63</volume><issue>2</issue><spage>563</spage><epage>570</epage><pages>563-570</pages><issn>1462-0324</issn><issn>1462-0332</issn><eissn>1462-0332</eissn><abstract>Autoantibody responses increase years before the onset of inflammatory arthritis (IA) and are stable during transitioning from clinically suspect arthralgia (CSA) to IA. Cytokine and chemokine levels also increase years before IA onset. However, the course in the at-risk stage of CSA during progression to disease or non-progression is unknown. To increase the understanding of processes mediating disease development, we studied the course of cytokine, chemokine and related receptors gene expression in CSA patients during progression to IA and in CSA patients who ultimately did not develop IA.
Whole-blood RNA expression of 37 inflammatory cytokines, chemokines and related receptors was determined by dual-colour reverse transcription multiplex ligation-dependent probe amplification in paired samples of CSA patients at CSA onset and either at IA development or after 24 months without IA development. ACPA-positive and ACPA-negative CSA patients developing IA were compared at CSA onset and during progression to IA. Generalised estimating equations tested changes over time. A false discovery rate approach was applied.
None of the cytokine/chemokine genes significantly changed in expression between CSA onset and IA development. In CSA patients without IA development, G-CSF expression decreased (P = 0.001), whereas CCR6 and TNIP1 expression increased (P < 0.001 and P = 0.002, respectively) over a 2 year period. Expression levels in ACPA-positive and ACPA-negative CSA patients who developed IA were similar.
Whole-blood gene expression of assessed cytokines, chemokines and related receptors did not change significantly from CSA to IA development. This suggests that changes in expression of these molecules may not be related to the final process of developing chronicity and may have occurred preceding CSA onset. Changes in gene expression in CSA patients without IA development may provide clues for processes related to resolution.</abstract><cop>England</cop><pmid>37280058</pmid><doi>10.1093/rheumatology/kead238</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2126-7922</orcidid><orcidid>https://orcid.org/0000-0002-3845-3019</orcidid><orcidid>https://orcid.org/0000-0003-3783-7042</orcidid><orcidid>https://orcid.org/0000-0002-5781-3817</orcidid><orcidid>https://orcid.org/0000-0001-8555-2872</orcidid><orcidid>https://orcid.org/0000-0001-8572-1437</orcidid><orcidid>https://orcid.org/0000-0001-6628-6222</orcidid><orcidid>https://orcid.org/0000-0002-3566-040X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1462-0324 |
| ispartof | Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.563-570 |
| issn | 1462-0324 1462-0332 1462-0332 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2823497237 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Arthralgia - genetics Arthritis, Rheumatoid - genetics Chemokines - genetics Cytokines - genetics Gene Expression Humans |
| title | The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T07%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20course%20of%20cytokine%20and%20chemokine%20gene%20expression%20in%20clinically%20suspect%20arthralgia%20patients%20during%20progression%20to%20inflammatory%20arthritis&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Heutz,%20Judith%20W&rft.date=2024-02-01&rft.volume=63&rft.issue=2&rft.spage=563&rft.epage=570&rft.pages=563-570&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kead238&rft_dat=%3Cproquest_cross%3E2823497237%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2823497237&rft_id=info:pmid/37280058&rfr_iscdi=true |